CATALENT FDA Approval ANDA 202807

ANDA 202807

CATALENT

FDA Drug Application

Application #202807

Application Sponsors

ANDA 202807CATALENT

Marketing Status

Over-the-counter001

Application Products

001CAPSULE;ORALEQ 200MG BASE0NAPROXEN SODIUMNAPROXEN SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2019-01-04
LABELING; LabelingSUPPL2AP2020-04-09STANDARD
LABELING; LabelingSUPPL3AP2020-04-09STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null7
SUPPL3Null7

CDER Filings

CATALENT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202807
            [companyName] => CATALENT
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"EQ 200MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/04\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"04\/09\/2020","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert, Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"04\/09\/2020","submission":"SUPPL-2","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2020-04-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.